HomeCompareKKRAF vs MRK

KKRAF vs MRK: Dividend Comparison 2026

KKRAF yields 1.81% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KKRAF wins by $42.34M in total portfolio value· pulled ahead in Year 3
10 years
KKRAF
KKRAF
● Live price
1.81%
Share price
$16.88
Annual div
$0.31
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$42.39M
Annual income
$38,334,131.35
Full KKRAF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — KKRAF vs MRK

📍 KKRAF pulled ahead of the other in Year 3

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKKRAFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KKRAF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
KKRAF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KKRAF
Annual income on $10K today (after 15% tax)
$154.18/yr
After 10yr DRIP, annual income (after tax)
$32,584,011.65/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, KKRAF beats the other by $32,575,683.24/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KKRAF + MRK for your $10,000?

KKRAF: 50%MRK: 50%
100% MRK50/50100% KKRAF
Portfolio after 10yr
$21.23M
Annual income
$19,171,964.74/yr
Blended yield
90.33%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

KKRAF
No analyst data
Altman Z
2.3
Piotroski
6/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KKRAF buys
0
MRK buys
0
No recent congressional trades found for KKRAF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKKRAFMRK
Forward yield1.81%2.76%
Annual dividend / share$0.31$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$42.39M$56.8K
Annual income after 10y$38,334,131.35$9,798.13
Total dividends collected$42.06M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: KKRAF vs MRK ($10,000, DRIP)

YearKKRAF PortfolioKKRAF Income/yrMRK PortfolioMRK Income/yrGap
1$11,063$362.77$11,206$366.19$143.00MRK
2$12,587$750.14$12,650$502.35$63.00MRK
3← crossover$15,064$1,595.36$14,407$694.19+$657.00KKRAF
4$19,687$3,568.68$16,585$967.82+$3.1KKKRAF
5$29,783$8,717.60$19,342$1,363.89+$10.4KKKRAF
6$56,518$24,650.65$22,913$1,947.19+$33.6KKKRAF
7$147,912$87,437.72$27,662$2,823.89+$120.3KKKRAF
8$585,988$427,721.82$34,159$4,173.35+$551.8KKKRAF
9$3,794,332$3,167,324.86$43,337$6,308.80+$3.75MKKRAF
10$42,394,066$38,334,131.35$56,776$9,798.13+$42.34MKKRAF

KKRAF vs MRK: Complete Analysis 2026

KKRAFStock

Katakura Industries Co.,Ltd. engages in the textile, pharmaceutical, machinery, real estate, and life solutions businesses in Japan. The company manufactures and sells undergarments, hosiery products, aprons, and relaxing garments, as well as various functional fibers, such as the water-soluble fiber solvron and the thermal resistant NITIVY ALF. It also engages in the manufacture and sale of pharmaceuticals for treating cardiovascular illnesses comprising Frandol for the treatment of angina pectoris; and Frandol Tape, a heart medicine. In addition, the company manufactures and sells environment-related equipment (washers) and cutting oil–related products, fire engines and firefighting-related equipment, and agricultural machinery, as well as car parts. Further, it provides commercial facility management services; and leases and develops various real estate lands. Additionally, the company offers agriculture-related products, food products, nursing care equipment, and general building maintenance and flower/tree planting services, as well as operates plant and pet specialty shops. The company was formerly known as Katakura Silk Spinning Co., Ltd. and changed its name to Katakura Industries Co.,Ltd. in November 1943. Katakura Industries Co.,Ltd. was founded in 1873 and is headquartered in Tokyo, Japan.

Full KKRAF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this KKRAF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KKRAF vs SCHDKKRAF vs JEPIKKRAF vs OKKRAF vs KOKKRAF vs MAINKKRAF vs JNJKKRAF vs ABBVKKRAF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.